Literature DB >> 12874781

MLL/SEPTIN6 chimeric transcript from inv ins(X;11)(q24;q23q13) in acute monocytic leukemia: report of a case and review of the literature.

Hee-Jin Kim1, Chang-Seok Ki, Quehn Park, Hong-Hoe Koo, Keon-Hee Yoo, Eun-Jeong Kim, Sun-Hee Kim.   

Abstract

Rearrangements of the MLL gene on chromosome 11, band q23, are one of the most common genetic changes in acute leukemia. Reciprocal translocation is the most common form of MLL rearrangement, and the partner genes in MLL translocation are notably diverse. Involvement of the SEPTIN6 gene on Xq24 in MLL rearrangements occurs very rarely, with only six cases having been documented in the literature. Of note, the MLL/SEPTIN6 rearrangements in these cases were cryptic or complex, and it was shown that the 5'-MLL/SEPTIN6-3' transcript resides on the derivative X chromosome rather than on the derivative chromosome 11 as in the majority of cases of MLL translocations. These observations suggested that MLL and SEPTIN6 reside on their respective chromosome loci in reverse orientation, that is, centromere-to-telomere and telomere-to-centromere, respectively. We here report a case of acute monocytic leukemia with inv ins(X;11)(q24;q23q13) in a 29-month-old child. Fluorescence in situ hybridization study revealed the break-apart 5'-MLL segment to be translocated to the derivative X chromosome, and reverse transcriptase-polymerase chain reaction followed by sequencing analysis confirmed the 5'-MLL/SEPTIN6-3' chimeric transcript. This case is the first to provide direct cytogenetic evidence for the salient nature of the MLL/SEPTIN6 rearrangement. We reviewed clinical and cytogenetic features of all cases of 11q23 and Xq22-24 rearrangements reported up to now, including six cases where the involvement of the SEPTIN6 gene was confirmed by molecular techniques. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874781     DOI: 10.1002/gcc.10235

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

Review 1.  Roles of a trithorax group gene, MLL, in hematopoiesis.

Authors:  Ryoichi Ono; Tetsuya Nosaka; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

2.  Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.

Authors:  Ryoichi Ono; Hideaki Nakajima; Katsutoshi Ozaki; Hidetoshi Kumagai; Toshiyuki Kawashima; Tomohiko Taki; Toshio Kitamura; Yasuhide Hayashi; Tetsuya Nosaka
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

3.  The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.

Authors:  Kinga Tóth; Orsolya Galamb; Sándor Spisák; Barnabás Wichmann; Ferenc Sipos; Gábor Valcz; Katalin Leiszter; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2011-01-26       Impact factor: 3.201

4.  Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.

Authors:  Claus Meyer; Bjoern Schneider; Martin Reichel; Sieglinde Angermueller; Sabine Strehl; Susanne Schnittger; Claudia Schoch; Mieke W J C Jansen; Jacques J van Dongen; Rob Pieters; Oskar A Haas; Theo Dingermann; Thomas Klingebiel; Rolf Marschalek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-30       Impact factor: 11.205

5.  Congenital X-linked neutropenia with myelodysplasia and somatic tetraploidy due to a germline mutation in SEPT6.

Authors:  Raffaele Renella; Katelyn Gagne; Ellen Beauchamp; Jonathan Fogel; Aleksej Perlov; Mireia Sola; Thorsten Schlaeger; Inga Hofmann; Akiko Shimamura; Benjamin L Ebert; Klaus Schmitz-Abe; Kyriacos Markianos; Kristi Murphy; Liang Sun; Shira Rockowitz; Piotr Sliz; Dean R Campagna; Timothy A Springer; Christopher Bahl; Suneet Agarwal; Mark D Fleming; David A Williams
Journal:  Am J Hematol       Date:  2021-11-03       Impact factor: 10.047

6.  Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.

Authors:  Kinga Tóth; Reinhold Wasserkort; Ferenc Sipos; Alexandra Kalmár; Barnabás Wichmann; Katalin Leiszter; Gábor Valcz; Márk Juhász; Pál Miheller; Árpád V Patai; Zsolt Tulassay; Béla Molnár
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

7.  Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome.

Authors:  Alain Chebly; Claudia Djambas Khayat; Tony Yammine; Rima Korban; Warde Semaan; Jessica Bou Zeid; Chantal Farra
Journal:  Leuk Res Rep       Date:  2021-10-26

8.  Clinical profile in KMT2A-SEPT6-positive acute myeloid leukemia: Does it often co-occur with NRAS mutations?

Authors:  Fang Chen; Ying Yang; Shuang Fu
Journal:  Front Med (Lausanne)       Date:  2022-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.